The Role of Fibrocytes in Acute Lung Injury

The important character of acute lung injury (ALI) is alveolar capillary membrane damage caused by different diseases, such as sepsis, trauma and shock. One of the important pathological stages is the...

Lead sponsor: Taipei Medical University WanFang Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

Not Yet Recruiting

Recovery of Physical Function After Critical Illness In Older Adults

NCT07225257 · Sepsis, Acute Lung Injury(ALI)

COMPLETEDNA

Dexmedetomidine Dose-Dependent on Lung Function and AQP1 in One-Lung Ventilation Surgery

NCT07145814 · Acute Lung Injury(ALI)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 14, 2011Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment20

Start dateJan 2011

Last updatedJun 14, 2011

Condition

Acute Lung Injury(ALI)

Locations shown

Taipei Medical University - WanFang Hospital

Taipei

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 14, 2011Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions